Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone

NCT02617628 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Opiate Dependence

Interventions

DRUG: extended release naltrexone

Sponsor

University of Pennsylvania

Collaborators

[object Object]